Pharmacology/ Therapeutics News for October 2010

New data published on anti-cancer isoquinolinamine derivatives New data published on anti-cancer isoquinolinamine derivatives

Rexahn Pharmaceuticals have announced the publication of new preclinical data on the development of 3-aryl-1-isoquinolinamines in the European Journal of Medicinal Chemistry.
19 October, 2010